Abstract
A reanalysis of 4-week data from a recently published study (Feighner et al. 1979) clearly demonstrate that in a significant subgroup of highly depressed patients who also suffer from at least moderate anxiety, significant treatment differences in favor of Limbitrol over AT were present not only after 1 or 2 weeks, but also after 4 weeks of treatment. These differences were not present in the less sick patients, a population in which AT was slightly favored.
These findings suggest that not only is Limbitrol more effective than AT alone for a heterogeneous group of depressed patients with some concomitant anxiety during the early phases of treatment, but remains more effective than AT for a significant subgroup of highly depressed patients after 4 weeks of treatment.
Similar content being viewed by others
References
American Psychiatric Association (1980) DSM-III-diagnostic and statistical manual of mental disorders, 3rd edn. Washington, D.C.
Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 19:1
Feighner JP, Brauzer B, Gelenberg AJ, Gomez E, Kiev A, Kurland ML, Weiss BL (1979) A placebo-controlled multicenter trial of Limbitrol versus its components (amitryptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology 61:217–225
Hamilton MA (1960) Rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Raskin A, Schulterbrandt JG, Reating N, McKeon JJ (1970) Differential response to chlorpromazine, imipramine, and placebo. Arch Gen Psychiatry 23:164
Rickels K (1971) Drug combination therapy in neurotic depression: Its advantages and disadvantages. Pharmakopsychiatr Neuropsychopharmakol 4:308–318
Rickels K, Hesbacher P, Downing RW (1970) Differential drug effects in neurotic depression. Dis Nerv Syst 31:468–475
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rickets, K. Limbitrol (amitriptyline plus chlordiazepoxide) revisited. Psychopharmacology 75, 31–33 (1981). https://doi.org/10.1007/BF00433497
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433497